应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MNKD 曼恩凯德生物医疗
盘前交易 02-19 09:16:32 EST
5.42
+0.00
0.00%
盘前
5.50
+0.08
+1.48%
09:12 EST
最高
5.48
最低
5.36
成交量
154.65万
今开
5.36
昨收
5.42
日振幅
2.21%
总市值
14.95亿
流通市值
14.67亿
总股本
2.76亿
成交额
839.81万
换手率
0.57%
流通股本
2.71亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
曼恩凯德生物医疗盘中异动 早盘急速跳水5.01%报5.50美元
市场透视 · 02-03
曼恩凯德生物医疗盘中异动 早盘急速跳水5.01%报5.50美元
曼恩凯德生物医疗盘中异动 股价大跌5.06%报6.48美元
市场透视 · 2024-12-30
曼恩凯德生物医疗盘中异动 股价大跌5.06%报6.48美元
曼恩凯德生物医疗盘中异动 早盘股价大涨5.16%报6.63美元
市场透视 · 2024-12-20
曼恩凯德生物医疗盘中异动 早盘股价大涨5.16%报6.63美元
美国研究综述-亚马逊、万事达卡、特斯拉
路透中文 · 2024-12-19
美国研究综述-亚马逊、万事达卡、特斯拉
曼恩凯德生物医疗盘中异动 股价大涨5.06%报6.23美元
市场透视 · 2024-12-18
曼恩凯德生物医疗盘中异动 股价大涨5.06%报6.23美元
曼恩凯德生物医疗盘中异动 股价大跌5.10%报5.95美元
市场透视 · 2024-12-17
曼恩凯德生物医疗盘中异动 股价大跌5.10%报5.95美元
BUZZ--美国股票走势-Candel Therapeutics、Broadcom、Reddit
Reuters · 2024-12-11
BUZZ--美国股票走势-Candel Therapeutics、Broadcom、Reddit
BUZZ--美国股票走势-埃克森美孚、Mondelez International、梅西百货
路透中文 · 2024-12-11
BUZZ--美国股票走势-埃克森美孚、Mondelez International、梅西百货
BUZZ-印度批准胰岛素吸入粉后,MannKind 公司业绩上升
Reuters · 2024-12-11
BUZZ-印度批准胰岛素吸入粉后,MannKind 公司业绩上升
曼恩凯德生物医疗盘中异动 快速下跌5.01%报6.38美元
市场透视 · 2024-11-26
曼恩凯德生物医疗盘中异动 快速下跌5.01%报6.38美元
曼恩凯德生物医疗2024财年第三财季实现净利润11.55百万美元,同比增加571.51%
市场透视 · 2024-11-16
曼恩凯德生物医疗2024财年第三财季实现净利润11.55百万美元,同比增加571.51%
曼恩凯德生物医疗盘中异动 临近午盘快速上涨5.32%报7.33美元
市场透视 · 2024-11-14
曼恩凯德生物医疗盘中异动 临近午盘快速上涨5.32%报7.33美元
曼恩凯德生物医疗盘中异动 早盘股价大跌9.42%
市场透视 · 2024-11-08
曼恩凯德生物医疗盘中异动 早盘股价大跌9.42%
MannKind Corp 预计每股收益3美分 - 财报前瞻
Reuters · 2024-11-06
MannKind Corp 预计每股收益3美分 - 财报前瞻
曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元
市场透视 · 2024-10-28
曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元
曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元
市场透视 · 2024-10-03
曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元
曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%
自选股智能写手 · 2024-08-19
曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%
曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%
自选股智能写手 · 2024-08-16
曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%
加载更多
公司概况
公司名称:
曼恩凯德生物医疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
Mannkind Corporation于1991年2月14日在美国特拉华州注册成立。Mannkind Corporation是一家生物制药公司,侧重于诸如糖尿病和癌症之类疗法和药品的开发、研制和推广。该公司的主导候选产品——AFREZZA吸入粉末,是一种超速效胰岛素,处于后期临床研究阶段,用于成人1型或2型糖尿病高血糖的控制治疗。AFREZZA是由该公司的专有技术圈颗粒加载到胰岛素分子里。这些加载的粒子雾化吸入后,会深入到使用AFREZZA吸入器的肺部。糖尿病是一个重大的健康问题。
发行价格:
--
{"stockData":{"symbol":"MNKD","market":"US","secType":"STK","nameCN":"曼恩凯德生物医疗","latestPrice":5.42,"timestamp":1739912400000,"preClose":5.42,"halted":0,"volume":1546526,"hourTrading":{"tag":"盘前","latestPrice":5.5,"preClose":5.42,"latestTime":"09:12 EST","volume":12080,"amount":66149.565392,"timestamp":1739974341710},"delay":0,"floatShares":270675143,"shares":275777693,"eps":0.079282,"marketStatus":"盘前交易","change":0,"latestTime":"02-19 09:16:32 EST","open":5.36,"high":5.48,"low":5.36,"amount":8398061.47465,"amplitude":0.02214,"askPrice":6.44,"askSize":100,"bidPrice":5.45,"bidSize":2052,"shortable":3,"etf":0,"ttmEps":0.079282,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1739975400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1090987200000,"exchange":"NASDAQ","adjPreClose":5.42,"preHourTrading":{"tag":"盘前","latestPrice":5.5,"preClose":5.42,"latestTime":"09:12 EST","volume":12080,"amount":66149.565392,"timestamp":1739974341710},"postHourTrading":{"tag":"盘后","latestPrice":5.45,"preClose":5.42,"latestTime":"18:43 EST","volume":47598,"amount":257999.51,"timestamp":1739922185667},"volumeRatio":0.9120622793949933,"impliedVol":0.5473,"impliedVolPercentile":0.852},"requestUrl":"/m/hq/s/MNKD","defaultTab":"news","newsList":[{"id":"2508144336","title":"曼恩凯德生物医疗盘中异动 早盘急速跳水5.01%报5.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508144336?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:49","pubTimestamp":1738594187,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时49分,曼恩凯德生物医疗股票出现波动,股价急速跳水5.01%。截至发稿,该股报5.50美元/股,成交量45.284万股,换手率0.16%,振幅2.25%。最近的财报数据显示,该股实现营业收入70.08百万美元,净利润11.55百万美元,每股收益0.04美元,毛利52.06百万美元,市盈率69.00倍。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.34%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322494798797234&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322494798797234&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2495478508","title":"曼恩凯德生物医疗盘中异动 股价大跌5.06%报6.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495478508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495478508?lang=zh_cn&edition=full","pubTime":"2024-12-31 04:38","pubTimestamp":1735591125,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日04时38分,曼恩凯德生物医疗股票出现异动,股价急速下跌5.06%。截至发稿,该股报6.48美元/股,成交量151.569万股,换手率0.55%,振幅4.11%。机构评级方面,在所有6家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为1.29%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231043845a20f77da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231043845a20f77da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2492444009","title":"曼恩凯德生物医疗盘中异动 早盘股价大涨5.16%报6.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492444009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492444009?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:37","pubTimestamp":1734705463,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时37分,曼恩凯德生物医疗股票出现波动,股价快速上涨5.16%。截至发稿,该股报6.63美元/股,成交量51.8372万股,换手率0.19%,振幅4.60%。机构评级方面,在所有6家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.25%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223743ab8767a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223743ab8767a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2492468114","title":"美国研究综述-亚马逊、万事达卡、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2492468114","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492468114?lang=zh_cn&edition=full","pubTime":"2024-12-19 14:58","pubTimestamp":1734591497,"startTime":"0","endTime":"0","summary":"美国研究综述-亚马逊、万事达卡、特斯拉路透12月19日 - 华尔街证券分析师周四调整了对亚马逊、万事达卡和特斯拉等多家美国上市公司的评级和目标价。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK0JV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB","ASLE","LU0096362180.USD","FHN","LU0444971666.USD","LU0820561909.HKD","LU1121112475.USD","LU1674673691.USD","FTNT","NET","MA","PANW","TSLA","LU0672654240.SGD","USAW.SI","LU1989772923.USD","GIS","WM","LU0708994859.HKD","UPWK","TPR","WOR","EAT","ZG","TGI","MNKD","VRNS","HXL","V","FI","AMZN","BROS","LU2456880835.USD","META","OKTA","IE00BJJMRY28.SGD","CRMD","ACHC","DSP","S","TSYW.SI","TENB","AIN","MNRO","TKO"],"gpt_icon":1},{"id":"2492184919","title":"曼恩凯德生物医疗盘中异动 股价大涨5.06%报6.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492184919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492184919?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:53","pubTimestamp":1734533614,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时53分,曼恩凯德生物医疗股票出现异动,股价快速上涨5.06%。截至发稿,该股报6.23美元/股,成交量52.322万股,换手率0.19%,振幅2.85%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.48%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822533595ea554e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822533595ea554e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2492965437","title":"曼恩凯德生物医疗盘中异动 股价大跌5.10%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492965437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492965437?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:43","pubTimestamp":1734446618,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时43分,曼恩凯德生物医疗股票出现异动,股价急速下跌5.10%。截至发稿,该股报5.95美元/股,成交量40.2456万股,换手率0.15%,振幅3.67%。最近的财报数据显示,该股实现营业收入70.08百万美元,净利润11.55百万美元,每股收益0.04美元,毛利52.06百万美元,市盈率74.88倍。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.56%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224338984c908b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224338984c908b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2490374862","title":"BUZZ--美国股票走势-Candel Therapeutics、Broadcom、Reddit","url":"https://stock-news.laohu8.com/highlight/detail?id=2490374862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490374862?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:18","pubTimestamp":1733933898,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 12月11日 - 华尔街主要股指周三上涨,此前的通胀数据维持了对美联储本月晚些时候降息的押注不变。美东时间10:30,道琼斯工业平均指数 上涨0.03%,报44,259.91点。标普500指数 上涨0.66%,报6,074.64点;纳斯达克综合指数 上涨1.26%,报19,935.91点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLD","M","EGP","DOG","CADL","AZO","FLNC","QID","RDDT","MNKD","IBRX","SDOW","QTTB","PDCO","DJX","GTLS","DNUT","ALK","XOM",".DJI","ACI","LOAR","ANVS","SFIX","FIGS","CGON","TQQQ","NQmain","RLAY",".SPX","RCKT",".IXIC","LENZ","UDOW","OMC","GM","QLD","LUV","CCB","AMZN","CLRB","PSQ","PLAY","MNQmain","AVGO","SIRI","MDLZ","AVGOP","GEV"],"gpt_icon":1},{"id":"2490850527","title":"BUZZ--美国股票走势-埃克森美孚、Mondelez International、梅西百货","url":"https://stock-news.laohu8.com/highlight/detail?id=2490850527","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490850527?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:11","pubTimestamp":1733926289,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC12G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2249611893.SGD","DNUT","SG9999014567.USD","LU1066053197.SGD","LU0738911758.USD","LU0130103400.USD","FIGS","LU0795875086.SGD","BK4559","LU1150488218.USD","MDLZ","FLNC","LU0170899867.USD","ALK","PLAY","LU1430597077.USD","M","RCKT","SFIX","LU0345770308.USD","GM","LU1732799900.SGD","LUV","LU0320765489.SGD","ANVS","LU2505996509.AUD","BK4077","GEV","LU0070302665.USD","CADL","LU0612318385.USD","QTTB","IBRX","RLAY","MNKD","CGON","EGP","PDCO","OMC","RJF","SIRI","LU1929549753.HKD","LU0011850046.USD","XOM","PLD","CLRB","SG9999015341.SGD","LU2602419157.SGD","LU1481011911.USD"],"gpt_icon":1},{"id":"2490985936","title":"BUZZ-印度批准胰岛素吸入粉后,MannKind 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2490985936","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490985936?lang=zh_cn&edition=full","pubTime":"2024-12-11 20:43","pubTimestamp":1733921027,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 12月11日 - ** 制药商MannKind 股价盘前上涨2.1%至6.81美元 ** MNKD和合作伙伴Cipla 称,印度中央药品标准控制组织(CDSCO) 已批准 (link) MNKD的胰岛素吸入粉Afrezza** 这两家公司表示,印度是全球糖尿病发病率第二高的国家** MNKD预计在2025年底前向CIPL交付产品** 根据协议,CIPL负责获得在印度分销Afrezza的监管批准以及市场营销和销售活动,而MNKD负责供应Afrezza。** 截至上次收盘,MNKD 年累计上涨 83.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2486015020","title":"曼恩凯德生物医疗盘中异动 快速下跌5.01%报6.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486015020","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486015020?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:43","pubTimestamp":1732632215,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时43分,曼恩凯德生物医疗股票出现异动,股价大幅下挫5.01%。截至发稿,该股报6.38美元/股,成交量64.4772万股,换手率0.23%,振幅3.63%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.50%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224336abe0c251&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224336abe0c251&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2484104905","title":"曼恩凯德生物医疗2024财年第三财季实现净利润11.55百万美元,同比增加571.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484104905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484104905?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773000,"startTime":"0","endTime":"0","summary":"11月17日,曼恩凯德生物医疗公布财报,公告显示公司2024财年第三财季净利润为11.55百万美元,同比增加571.51%;其中营业收入为70.08百万美元,同比增加36.74%,每股基本收益为0.04美元。从资产负债表来看,曼恩凯德生物医疗总负债6.74亿美元,其中短期债务13.07百万美元,资产负债比为0.69,流动比率为0.05。机构评级:截至2024年11月17日,当前有5家机构对曼恩凯德生物医疗目标价做出预测,其中目标均价为9.40美元,其中最低目标价为7.00美元,最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000435a23e0722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000435a23e0722&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2483384721","title":"曼恩凯德生物医疗盘中异动 临近午盘快速上涨5.32%报7.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483384721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483384721?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:55","pubTimestamp":1731603324,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时55分,曼恩凯德生物医疗股票出现异动,股价快速拉升5.32%。截至发稿,该股报7.33美元/股,成交量136.357万股,换手率0.49%,振幅5.89%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.64%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115005525971a69c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115005525971a69c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2481101760","title":"曼恩凯德生物医疗盘中异动 早盘股价大跌9.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101760?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076368,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分,曼恩凯德生物医疗股票出现波动,股价急速下挫9.42%。截至发稿,该股报6.69美元/股,成交量50.0499万股,换手率0.18%,振幅5.68%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.42%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324895bdef38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324895bdef38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2481361398","title":"MannKind Corp 预计每股收益3美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481361398","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481361398?lang=zh_cn&edition=full","pubTime":"2024-11-06 11:43","pubTimestamp":1730864638,"startTime":"0","endTime":"0","summary":" * MannKind公司 预计在11月7日公布截至2024年9月30日的财报时,季度收入将出现增长。* 根据LSEG的数据,3位分析师的平均预期显示,这家总部位于康涅狄格州丹伯里的公司的营收预计将从去年同期的5125万美元增长45.4%,达到7450万美元。* LSEG分析师对MannKind公司的平均预期为每股收益3美分。* 华尔街对 MannKind 公司 12 个月目标价的中位数为 7.50 美元,高于其最新收盘价 7.26 美元。11月6日 - 以往季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MannKind Corp 预计每股收益3美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD"],"gpt_icon":0},{"id":"2478148734","title":"曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478148734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478148734?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:44","pubTimestamp":1730126676,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时44分,曼恩凯德生物医疗股票出现异动,股价急速拉升5.20%。截至发稿,该股报6.88美元/股,成交量50.734万股,换手率0.18%,振幅4.20%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.58%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224437ab7becba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224437ab7becba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2472673611","title":"曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472673611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472673611?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:07","pubTimestamp":1727964437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时07分,曼恩凯德生物医疗股票出现波动,股价大幅上涨5.17%。截至发稿,该股报6.62美元/股,成交量69.1327万股,换手率0.25%,振幅5.41%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.63%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220717ab6799a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220717ab6799a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2460703209","title":"曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460703209","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460703209?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:57","pubTimestamp":1724075820,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时57分,曼恩凯德生物医疗股票出现波动,股价快速上涨5.06%。截至发稿,该股报5.40美元/股,成交量44.2137万股,换手率0.16%,振幅4.14%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为1.00%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192157019719924e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192157019719924e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2460492652","title":"曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460492652","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460492652?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824030,"startTime":"0","endTime":"0","summary":"8月17日,曼恩凯德生物医疗公布财报,公告显示公司2024财年第二财季净利润为-2.01百万美元,同比增加61.86%;其中营业收入为72.39百万美元,同比增加48.92%,每股基本收益为-0.01美元。从资产负债表来看,曼恩凯德生物医疗总负债6.70亿美元,其中短期债务13.10百万美元,资产负债比为0.67,流动比率为0.05。机构评级:截至2024年8月17日,当前有5家机构对曼恩凯德生物医疗目标价做出预测,其中目标均价为7.30美元,其中最低目标价为5.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004429f31afb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004429f31afb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mannkindcorp.com","stockEarnings":[{"period":"1week","weight":-0.0287},{"period":"1month","weight":-0.0982},{"period":"3month","weight":-0.2122},{"period":"6month","weight":0.0169},{"period":"1year","weight":0.4849},{"period":"ytd","weight":-0.1571}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0233},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.0994},{"period":"1year","weight":0.2242},{"period":"ytd","weight":0.0434}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mannkind Corporation于1991年2月14日在美国特拉华州注册成立。Mannkind Corporation是一家生物制药公司,侧重于诸如糖尿病和癌症之类疗法和药品的开发、研制和推广。该公司的主导候选产品——AFREZZA吸入粉末,是一种超速效胰岛素,处于后期临床研究阶段,用于成人1型或2型糖尿病高血糖的控制治疗。AFREZZA是由该公司的专有技术圈颗粒加载到胰岛素分子里。这些加载的粒子雾化吸入后,会深入到使用AFREZZA吸入器的肺部。糖尿病是一个重大的健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.038436},{"month":2,"riseRate":0.380952,"avgChangeRate":-0.007363},{"month":3,"riseRate":0.45,"avgChangeRate":-0.008047},{"month":4,"riseRate":0.4,"avgChangeRate":-0.028112},{"month":5,"riseRate":0.55,"avgChangeRate":0.120551},{"month":6,"riseRate":0.55,"avgChangeRate":0.062891},{"month":7,"riseRate":0.3,"avgChangeRate":-0.060302},{"month":8,"riseRate":0.428571,"avgChangeRate":0.006818},{"month":9,"riseRate":0.666667,"avgChangeRate":0.074573},{"month":10,"riseRate":0.47619,"avgChangeRate":-0.038748},{"month":11,"riseRate":0.428571,"avgChangeRate":0.022771},{"month":12,"riseRate":0.52381,"avgChangeRate":-0.017116}],"exchange":"NASDAQ","name":"曼恩凯德生物医疗","nameEN":"MannKind"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.1","shortVersion":"4.31.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"曼恩凯德生物医疗,MNKD,曼恩凯德生物医疗股票,曼恩凯德生物医疗股票老虎,曼恩凯德生物医疗股票老虎国际,曼恩凯德生物医疗行情,曼恩凯德生物医疗股票行情,曼恩凯德生物医疗股价,曼恩凯德生物医疗股市,曼恩凯德生物医疗股票价格,曼恩凯德生物医疗股票交易,曼恩凯德生物医疗股票购买,曼恩凯德生物医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}